This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of levodopa decarboxylase inhibitor
PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
N04BA02
1 out of 7 registries used, show all original rules.
4053
Check minimum number of events
Min. number of events
3
4053
Include endpoints None
4053
Remove individuals based on genotype QC
3941
PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of levodopa decarboxylase inhibitor
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3941 | 1583 | 2358 |
| Unadjusted prevalence (%) | 0.96 | 0.69 | 1.30 |
| Mean age at first event (years) | 69.43 | 68.20 | 70.26 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of levodopa decarboxylase inhibitor
↥Endpoint not on priority list, no data to show.